1 Stock Down 15% This Year to Buy and Hold Forever
The past three years have been a roller coaster for Abbott Laboratories (NYSE: ABT). The healthcare giant dealt with a slowdown in its medical device business caused by the pandemic, fluctuating sales of its coronavirus diagnostic tests, and a recall of some of its baby formula products. Abbott's financial results haven't been consistent, partly explaining why it has lagged the market this year.
However, there remain excellent reasons to buy shares of the company. Let's consider why Abbott Labs is an outstanding "forever" stock.
Source Fool.com
Abbott Laboratories Stock
Abbott Laboratories is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
With a target price of 116 € there is a slightly positive potential of 17.91% for Abbott Laboratories compared to the current price of 98.38 €.